febf99bb94dd7d8e349572626d23699d.jpg

3D Systems Secures FDA Clearance to Broaden Adolescent Use of VSP Orthopedics Platform

by Medical

US-based 3D printer manufacturer 3D Systems has received U.S. Food and Drug Administration 510(k) clearance broadening the approved use of its VSP Orthopedics virtual surgical planning and patient-specific instrumentation platform. The clearance now covers skeletally mature adolescents with normal bone structure, in addition to adult patients. This change removes previous regulatory constraints that limited use in adolescent cases and formally brings these procedures within the platform’s labeled indications.

3D Printed Biodegradable Scaffolds Offer Potential for Improved Heart Bypass Grafts

by Medical

Researchers at the U.S. private research universities Worcester Polytechnic Institute in Massachusetts and Northwestern University in Illinois have developed a method for producing small, biodegradable tubular scaffolds using 3D printing. The scaffolds feature microscopic grooves and channels designed to guide cell growth, with the goal of supporting the regeneration of functional blood vessels.

cf9a541aa8b83c3b81dca0772ab75c5b.jpg

Qase3D and Waveland introduce MDR Management System

by Medical

Qase3D, a company focused on regulatory compliance and quality systems for medical 3D printing operations, has partnered with Waveland European Lawyers to introduce an MDR Management System for hospital-based Point-of-Care (PoC) 3D printing labs. The system addresses compliance with the European Medical Device Regulation (MDR) for facilities producing custom-made medical devices, including anatomical models, surgical guides, and patient-specific implants used in clinical settings.

dcc89f1679befc09a8411ec488dd8b40.jpg

ARPA-H Launches THEA Program to Advance Whole Eye Transplantation

by Medical

The Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services, has announced award recipients under its Transplantation of Human Eye Allografts (THEA) program. With funding of up to $125 million, the initiative aims to develop the first complete human eye transplantation procedure, targeting restoration of vision for people who are blind or visually impaired.

b9705e57c12f427209f4d9de011eacba.jpg

RadioMatrix: Stratasys Expands Access to Patient-Specific Radiopaque 3D Printing for Medical Imaging

by Medical

3D printer OEM Stratasys has announced that its RadioMatrix radiopaque 3D printing material is now fully commercially available in the United States. Previously deployed in limited settings, the material can now be widely used by healthcare providers, medical device manufacturers, and research institutions for advanced medical imaging, education, and training purposes.

Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing

by Medical

In pharmaceutical manufacturing, tablets have long been produced through standardized processes that leave little room for fine-tuning how a drug behaves once ingested. Chinese pharmaceutical technology company Triastek is challenging that model. By applying 3D printing to drug product development and manufacturing, the company is introducing a more controlled and predictable way to engineer oral medications.